Autonomic function and autoantibodies to autonomic nervous tissues at follow-up in a cohort of young patients with type 1 diabetes: Effects of serum from diabetic patients on human adrenergic cells

Journal of Neuroimmunology

Volumn 139, Issue 1-2, 2003, Pages 66-75

  Zanone, Maria M ^a   Favaro, Enrica ^a   Catalfamo, Edoardo ^a   Quadri, Roberto ^a   Sacchetti, Carla ^b   Cerutti, Franco ^b   Perin, Paolo Cavallo ^a   Camussi, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Apoptosis; Cardiovascular tests; Diabetic autonomic neuropathy; Nervous tissue autoantibodies; Neuroblastoma cells

Indexed keywords

ADOLESCENT; ADRENERGIC NERVE CELL; ADRENERGIC SYSTEM; ADULT; APOPTOSIS; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CELL LINE; CELL MEMBRANE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; DISEASE SEVERITY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA CELL; NICK END LABELING; PRIORITY JOURNAL;

EID: 0037870412     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00129-2     Document Type: Article

References (51)

1. Aman J., Eriksson E., Lideen J. Autonomic nerve function in children and adolescents with insulin-dependent diabetes mellitus. Clin. Physiol. 11:1991;537-543.
2. Bongiovanni L.G., Pinelli L., Cirillo D., Coccia G., Fiaschi A., Gonfiantini E., Perbellini T., Polo A., De Grandis D. Assessment of autonomic functions in insulin-dependent diabetic children and adolescents. Funct. Neurology. 3:1988;47-54.
3. Donaughue K.C., Fung A.T.W., Fairchild J.M., Howard N.J., Silink M. Prospective assessment of autonomic and peripheral nerve function in adolescents with diabetes. Diabet. Med. 13:1996;65-71.
4. Duck S.C., Wei F., Parke J., Swick H.M. Role of height and glycosylated hemoglobin in abnormal nerve conduction in pediatric patients with type 1 diabetes mellitus after 4-9 yr of disease. Diabetes Care. 14:1991;386-392.
5. Dyck P.J. Detection, characterization and staging of polyneuropathy: assessed in diabetics. Muscle Nerve. 11:1988;21-32.
6. Ejskjaer N., Zanone M.M., Peakman M. Autoimmunity in diabetic autonomic neuropathy: does the immune system get on your nerves? Diabet. Med. 15:1998;723-729.
7. Ejskjaer N., Arif S., Dodds W., Zanone M.M., Vergani D., Watkins P.J., Peakman M. Prevalence of autoantibodies to autonomic nervous tissue structures in type 1 diabetes mellitus. Diabet. Med. 16:1999;544-549.
8. Eng G.D., Hung W., August G.P., Smokvina M.D. Nerve conduction velocity determinations in juvenile diabetes: continuing study of 190 patients. Arch. Phys. Med. Rehabil. 57:1979;1-5.
9. Ewing D.J., Clarke B.F. Diagnosis and management of diabetic autonomic neuropathy. Br. Med. J. 285:1982;916-918.
10. Ewing D.J., Martyn C.N., Young R.J., Clarke B.F. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 8:1985;491-498.
11. Fishelson Z., Attali G., Mevorach D. Complement and apoptosis. Mol. Immunol. 38:2001;207-219.
12. Gadia M.T., Natori N., Ramos L.B., Ayyar D.R., Skyler J.S., Sosenko J.M. Influence of height on quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy. Diabetes Care. 10:1987;613-616.
13. Gamstorp I., Shelburne S.A., Engleson G., Redondo D., Traisman H.S. Peripheral neuropathy in juvenile diabetes. Diabetes. 15:1966;411-418.
14. Gold R., Schmied M., Giegerich G., Breitschopf H., Hartung H.P., Toyka K.V., Lassmann H. Differentiation between cellular apoptosis and necrosis by combined use of in situ tailing and nick translation techniques. Lab. Invest. 71:1994;219-225.
15. Hoeldtke R.D., Bryner K.D., Hobbs G.R., Harvarth G.G., Riggs J.E., Christie I., Ganser G., Marcovina S.M., Lernmark A. Autoantibodies to glutamic acid decarboxylase and peripheral nerve function in type 1 diabetes. J. Clin. Endocr. Metab. 85:2000;3297-3308.
16. Karachaliou F., Karavanaki K., Greenwood R., Baum J.D. Consistence of pupillary abnormality in children and adolescents with diabetes. Diabetic. Med. 14:1997;849-853.
17. Kroesen B.J., Mesander G., Har J.G., The T.H., de Leij L. Direct visualisation and quantification of cellular cytotoxicity using two colour fluorescence. J. Immunol. Methods. 142:1992;47-55.
18. Levitt N.S., Stansberry K.B., Wynchank S., Vinik A.I. The natural progression of autonomic neuropathy and autonomic function tests in a cohort of people with IDDM. Diabetes Care. 19:1996;751-754.
19. Ludvigsson J., Johannesson G., Heding L., Hager A., Larsson Y. Sensory nerve conduction velocity and vibratory sensibility in juvenile diabetics: relationship to endogenous insulin. Acta Paediatr. Scand. 68:1979;739-743.
20. Maser R.E., Pfeifer M.A., Dorman J.S., Kuller L.H., Becker D.J., Orchard T.J. Diabetic autonomic neuropathy and cardiovascular risk. Arch. Intern. Med. 150:1990;1218-1222.
21. Mitchell E.A., Wealthall S.R., Elliott R.B. Diabetic autonomic neuropathy in children: immediate heart-rate response to standing. Aust. Paediatr. J. 19:1983;175-177.
22. Morgan B.P. Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem. J. 264:1989;1-14.
23. Muhr D., Mollenhauer U., Ziegler A.G., Haslbeck M., Standl E., Schnell O. Autoantibodies to sympathetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy. Diabetes Care. 20:1997;1009-1012.
24. Muhr-Becker D., Ziegler A.G., Druschky A., Wolfram G., Haslbeck M., Neundörfer B., Standl E., Schnell O. Evidence for specific autoimmunity against sympathetic and parasympathetic nervous tissues in type 1 diabetes mellitus and the relation to cardiac autonomic dysfunction. Diabet. Med. 15:1998;467-472.
25. O'Brien I.A.D., O'Hare P., Corral R.J.M. Heart rate variability in healthy subjects: effect of age and derivation of normal ranges for tests of autonomic function. Br. Heart J. 55:1986;348-354.
26. Pena M.M., Donaughe K.C., Fung A.T.W., Bonney M., Schwingshandl J., Howard N.J., Silink M. The prospective assessment of autonomic nerve function by pupillometry in adolescents with type 1 diabetes mellitus. Diabet. Med. 12:1995;868-873.
27. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabet. Metab. 3:1977;97-107.
28. Pittenger G.L., Liu D., Vinik A.I. The toxic effects of serum from patients with type 1 diabetes mellitus on mouse neuroblastoma cells: a new mechanism for development of diabetic autonomic neuropathy. Diabet. Med. 10:1993;925-932.
29. Pittenger G.L., Liu D., Vinik A.I. The neuronal toxic factor in serum of type 1 diabetic patients is a complement-fixing autoantibody. Diabet. Med. 12:1995;380-386.
30. Pittenger G.L., Liu D., Vinik A.I. The apoptotic death of neuroblastoma cells caused by serum from patients with insulin-dependent diabetes and neuropathy may be FAS-mediated. J. Neuroimmunol. 76:1997;153-160.
31. Ringel R.E., Chalew S.A., Armour K.A., McLaughlin J., McCarter R.J., Kramer W.E. Cardiovascular reflex abnormalities in children and adolescents with diabetes mellitus. Diabetes Care. 16:1993;734-741.
32. Roos A., Sato T., Maier H., van Kooten C., Daha M.R. Induction of renal cell apoptosis by antibodies and complement. Exp. Nephrol. 9:2001;65-70.
33. Schnell O., Muhr D., Dresel S., Tatsch K., Ziegler A.G., Haslbeck M., Standl E. Autoantibodeis against sympathetic ganglia and evidence of cardiac sympathetic dysinnervation in newly diagnosed and long-term IDDM patients. Diabetologia. 39:1996;970-975.
34. Schwingshandl J., Simpson J.M., Donaghue K., Bonney M.A., Howard N.J., Silink M. Pupillary abnormalities in type I diabetes occurring during adolescence. Diabetes Care. 16:1993;630-633.
35. Sima A.A.F., Nathaniel V., Bril V., McEwen T.A.J., Greene D.A. Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy. J. Clin. Invest. 81:1988;349-364.
36. Sima A.A.F., Thomas P.K., Ishii D., Vinik A. Diabetic neuropathies. Diabetologia. 40:1997;B74-B77.
37. Solders G., Thalme B., Aguirre-Aquino M., Brandt L., Berg U., Persson A. Nerve conduction and autonomic nerve function in diabetic children. A 10-year follow-up. Acta Paediatr. 86:1997;361-366.
38. Spallone V., Maiello M.R., Cicconetti E., Mezinger G. Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes. Diabetes Res. Clin. Pract. 34:1997;169-179.
39. Srinivasan S., Stevens M.J., Sheng H., Hall K.E., Wiley J.W. Serum from patients with type 2 diabetes with neuropathy induces complement-independent, calcium-dependent apoptosis in cultured neuronal cells. J. Clin. Invest. 102:1998;1454-1462.
40. Stevens M.J., Raffel D.M., Allman K.C., Schwaiger M., Wieland D.M. Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: an assessment by C-1 hydroxyephedrine and positron emission tomography. Metabolism. 48:1999;92-101.
41. Sundkvist G., Lilja B. Autonomic neuropathy in diabetes mellitus: a follow-up study. Diabetes Care. 8:1985;129-133.
42. The DCTT Research Group Factors in development of diabetic neuropathy: baseline analysis of neuropathy in feasibility phase of diabetes control and complications trial (DCCT). Diabetes. 37:1988;476-481.
43. The Diabetes Control and Complications Trial Research Group The DCCT Research Group: the effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:1993;977-986.
44. Vernino S., Low P.A., Fealey R.D., Stewart J.D., Farrugia G., Lennon V.A. Autoantibodies to ganglionic acetylcholine receptors in autoimmune neuropathies. N. Engl. J. Med. 343:2000;847-855.
45. Wieling W., Van Brederode J.F.M., De Rijk L.G., Borst C., Dunning A.J. Reflex control of heart rate in normal subjects in relation to age: a data base for cardiac vagal neuropathy. Diabetologia. 22:1982;163-166.
46. Yagihashi S. Pathology and pathogenetic mechanisms of diabetic neuropathy. Sima A.A.F., Ward J.D. Nervous System Abnormalities in Diabetes. Diabetes Metab. Rev. vol. 11:1995;193-226.
47. Young R.J., Ewing D.J., Clarke B.F. Nerve function and metabolic control in teenage diabetics. Diabetes. 32:1983;142-147.
48. Young R.J., Macintyre C.C.A., Martyn C.N., Prescott R.J., Ewing D.J., Smith A.F., Viberti G., Clarke B.F. Progression of subclinical polyneuropathy in young patients with type 1 (insulin dependent) diabetes: association with glycaemic control and microangiopathy (microvascular complications). Diabetologia. 29:1986;156-161.
49. Zanone M.M., Burchio S., Quadri R., Pietropaolo M., Sacchetti C., Robbone I., Chiandussi L., Cerruti F., Peakman M. Autonomic function and autoantibodies to autonomic nervous structures, glutamic acid decarboxylase and islet tyrosine phosphatase in adolescent patients with IDDM. J. Neuroimmunol. 87:1998;1-10.
50. Zanone M.M., Peakman M., Purewal T., Watkins P.J., Vergani D. Autoantibodies to autonomic nervous structures are associated with autonomic neuropathy in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 36:1993;564-569.
51. Ziegler D., Mayer P., Mühlen Gries F.A. The natural history of somatosensory and autonomic nerve dysfunction to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 34:1991;822-829.